Rockwell Medical is adding new business within the Minnesota region. Rockwell started to supply these clinics with its hemodialysis concentrates products effective December 5, anticipates that all clinics will be onboarded by January 1, 2023, and expects to generate over $1M in revenue the first year. In the U.S., the in-center hemodialysis concentrates market is currently valued at $380M and is anticipated to grow to approximately $500M by 2026, driven primarily by an increasing number of patients suffering from end-stage kidney disease. Rockwell believes it is well-positioned to achieve annual revenue of $100M in the next few years.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on RMTI: